ProMIS Neurosciences Inc. Asset Resilience Ratio

Latest as of September 2025: 0.15%

ProMIS Neurosciences Inc. asset resilience ratio. ProMIS Neurosciences Inc. (PMN) has an Asset Resilience Ratio of 0.15% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of ProMIS Neurosciences Inc. to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$33.05K

Cash + Short-term Investments

Total Assets

$21.46 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of ProMIS Neurosciences Inc. (2005–2024)

Asset resilience ratio of ProMIS Neurosciences Inc. from 2005 to 2024. This chart shows how ProMIS Neurosciences Inc.'s Asset Resilience Ratio has changed over time. Read ProMIS Neurosciences Inc. balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down ProMIS Neurosciences Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ProMIS Neurosciences Inc. asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$33.05K	0.15%
Total Liquid Assets	$33.05K	0.15%

Asset Resilience Insights

Limited Liquidity: ProMIS Neurosciences Inc. maintains only 0.15% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

ProMIS Neurosciences Inc. Industry Peers by Asset Resilience Ratio

Compare ProMIS Neurosciences Inc.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

ProMIS Neurosciences Inc. Asset Resilience Ratio by Year (2005–2024)

ProMIS Neurosciences Inc. asset resilience ratio by year from 2005 to 2024. The table below shows the annual Asset Resilience Ratio data for ProMIS Neurosciences Inc..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.17%	$33.05K	$18.91 Million	-0.06pp
2023-12-31	0.24%	$32.36K	$13.62 Million	-0.40pp
2022-12-31	0.63%	$59.46K	$9.38 Million	+0.41pp
2021-12-31	0.23%	$50.69K	$22.44 Million	-5.31pp
2020-12-31	5.54%	$76.72K	$1.38 Million	+3.52pp
2019-12-31	2.02%	$41.83K	$2.07 Million	+0.61pp
2018-12-31	1.40%	$41.62K	$2.97 Million	-0.50pp
2017-12-31	1.91%	$41.41K	$2.17 Million	-1.66pp
2015-12-31	3.56%	$41.00K	$1.15 Million	-73.35pp
2009-12-31	76.91%	$4.08 Million	$5.31 Million	+1.49pp
2008-12-31	75.42%	$3.30 Million	$4.37 Million	+10.68pp
2007-12-31	64.74%	$6.28 Million	$9.71 Million	-18.01pp
2006-12-31	82.75%	$10.57 Million	$12.77 Million	-11.92pp
2005-12-31	94.67%	$4.51 Million	$4.76 Million	--

pp = percentage points

About ProMIS Neurosciences Inc.

NASDAQ:PMN USA Biotechnology

Market Cap

$7.34 Million

Market Cap Rank

#27679 Global

#5729 in USA

Share Price

$3.41

Change (1 day)

+13.67%

52-Week Range

$0.29 - $24.79

All Time High

$35.40